Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Addus HomeCare Corporation - Common Stock (NQ:ADUS)

111.86 +1.49 (+1.35%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Addus HomeCare Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Addus HomeCare to Participate in TD Cowen 45th Annual Health Care Conference
From Addus HomeCare Corporation
Via Business Wire
What To Expect From Chemed’s (CHE) Q4 Earnings
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what to expect. 
Via StockStory
Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect
Alternate site health provider Option Care Health (NASDAQ:OPCH) will be reporting earnings tomorrow before market open. Here’s what to look for. 
Via StockStory
Addus HomeCare (NASDAQ:ADUS) Surprises With Q4 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of... 
Via StockStory
Deep Dive Into Addus HomeCare Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Is NASDAQ:ADUS a Suitable Choice for Quality Investing?
Why Quality Investors May Find ADDUS HOMECARE CORP (NASDAQ:ADUS) Attractive. 
Via Chartmill
Should you consider ADDUS HOMECARE CORP (NASDAQ:ADUS) for quality investing?
Should Quality-Oriented Investors Explore ADDUS HOMECARE CORP (NASDAQ:ADUS)? 
Via Chartmill
Assessing Addus HomeCare: Insights From 9 Financial Analysts
Via Benzinga
Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results
From Addus HomeCare Corporation
Via Business Wire
Earnings Scheduled For February 24, 2025
Via Benzinga
The Analyst Verdict: Addus HomeCare In The Eyes Of 9 Experts
Via Benzinga
Demystifying Addus HomeCare: Insights From 8 Analyst Reviews
Via Benzinga
Addus HomeCare (ADUS) To Report Earnings Tomorrow: Here Is What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings tomorrow after market hours. Here’s what to look for. 
Via StockStory
Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers. 
Via StockStory
Topics Economy
Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers. 
Via StockStory
Topics Economy
Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice... 
Via StockStory
Topics Economy
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Via Benzinga
Analyst Scoreboard: 6 Ratings For Addus HomeCare
Via Benzinga
Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare... 
Via StockStory
Topics Economy
Addus HomeCare Announces Fourth Quarter and Year-end 2024 Earnings Release and Conference Call
From Addus HomeCare Corporation
Via Business Wire
DaVita Stock Sees Improved Relative Strength Rating
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72. 
Via Investor's Business Daily
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
JMP Securities begins coverage of Addus HomeCare Corp with a $150 price target, highlighting expansion plans, strategic acquisitions, and strong revenue growth. 
Via Benzinga
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Addus HomeCare Completes Acquisition of Personal Care Operations of Gentiva
From Addus HomeCare Corporation
Via Business Wire
Addus HomeCare to Participate in Stephens Annual Investment Conference
From Addus HomeCare Corporation
Via Business Wire
Addus HomeCare Announces Third Quarter 2024 Financial Results
From Addus HomeCare Corporation
Via Business Wire
Addus HomeCare Announces Third Quarter 2024 Earnings Release and Conference Call
From Addus HomeCare Corporation
Via Business Wire
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
Reasonable growth and debt and a high ROIC for ADDUS HOMECARE CORP (NASDAQ:ADUS).
ADDUS HOMECARE CORP (NASDAQ:ADUS) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
ADUS Stock Earnings: Addus HomeCare Beats EPS, Beats Revenue for Q2 2024
ADUS stock results show that Addus HomeCare beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.